Skip to main content
NIH funding notice PA-18-044

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)

Closed on January 7, 2020.

Posted
November 3, 2017
Close date
January 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $62,031 in first-year total cost, median $62,031.

Most frequent study sections

  1. Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]1

Most frequent institutions

  1. QUEEN'S UNIVERSITY AT KINGSTON1
Competing awards under PA-18-044 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019A Population-Based Study to Quantify the Risks of Opioid Analgesics in Pregnancy1R03HD099617-01BROGLY, SUSAN BQUEEN'S UNIVERSITY AT KINGSTON, ON$62,031IRAP

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-044: Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional) | ScienceDex | ConductScience